Table 4.
Adverse events and frequency (occurring in ≥30%) (left panel) and ≥grade 3 adverse events and frequency (occurring in ≥10%) (right panel) of 526 patients enrolled in PX-171-003- A0, PX-171-003-A1, PX-171-004, and PX-171-005 trials
Adverse event | Frequency (%) | ≥grade 3 adverse event | Frequency (%) |
---|---|---|---|
Fatigue | 55 | Thrombocytopenia | 23 |
Anemia | 47 | Anemia | 22 |
Nausea | 42 | Lymphopenia | 18 |
Thrombocytopenia | 36 | Pneumonia | 11 |
Dyspnea | 35 | Neutropenia | 10 |
Diarrhea | 33 | ||
Pyrexia | 30 |